Connections between Cognitive Impairment and Atrial Fibrillation in Patients with Diabetes Mellitus Type 2
M Militaru, DF Lighezan, C Tudoran, AG Militaru - Biomedicines, 2024 - mdpi.com
(1) Background: Cognitive decline (CD), considered a precursory state of dementia, is
frequently encountered in patients with diabetes mellitus type 2 (DM-2) and might even have …
frequently encountered in patients with diabetes mellitus type 2 (DM-2) and might even have …
[HTML][HTML] Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study
A Linares Ballesteros, R Sanguino Lobo… - Colombia …, 2021 - scielo.org.co
Background: Acute leukemias are the most frequent malignancies in children. Advances in
treatment have improved the overall survival to 80%. Almost 10% of children with cancer …
treatment have improved the overall survival to 80%. Almost 10% of children with cancer …
Application of High‐Quality Nursing Intervention Based on Humanistic Care Combined with the Project Teaching Method in Patients with Acute Leukemia Undergoing …
Z Wang - Journal of Healthcare Engineering, 2022 - Wiley Online Library
Chemotherapy, the main treatment method of AL, can produce varying degrees of toxic and
side effects on patients while killing tumor cells, resulting in decreased immune function of …
side effects on patients while killing tumor cells, resulting in decreased immune function of …
Machine Learning-Based ECG Signal Classification for Enhanced Early Detection of Doxorubicin-Induced Cardiotoxicity in Rats
Cardiotoxicity, which leads to irreversible myocardial damage, is a major adverse effect
associated with chemotherapy. Electrocardiogram (ECG) is an inexpensive, rapid, and …
associated with chemotherapy. Electrocardiogram (ECG) is an inexpensive, rapid, and …
Особенности нарушения сократительной способности миокарда у больных хроническим лимфолейкозом в процессе химиотерапии и их коррекция …
ИЛ Давыдкин, ТП Кузьмина… - Российский …, 2020 - cyberleninka.ru
Цель. Оценка нарушений сократительной способности левого желудочка (ЛЖ) в
процессе химиотерапии по схеме FCR (флударабин, циклофосфамид, ритуксимаб) у …
процессе химиотерапии по схеме FCR (флударабин, циклофосфамид, ритуксимаб) у …
Sildenafil for Primary Prevention of Anthracycline‐Induced Cardiac Toxicity: A Phase I/II Randomized Clinical Trial, SILDAT‐TAHA6 Trial
Background. Previous animal studies have shown a protective effect of 5‐
phosphodiesterase inhibitors on cancer therapeutics‐related cardiac dysfunction (CTRCD) …
phosphodiesterase inhibitors on cancer therapeutics‐related cardiac dysfunction (CTRCD) …
IMPACT OF CANCER TREATMENT ON PULSE WAVE VELOCITY IN CANCER SURVIVORS: A META-ANALYSIS
J Levet-Bourtayre - 2023 - cdr.lib.unc.edu
Cancer survivors are at an increased risk of morbidities such as cardiovascular diseases
(CVD). Cancer treatments such as chemotherapy and radiation have been correlated with …
(CVD). Cancer treatments such as chemotherapy and radiation have been correlated with …
[HTML][HTML] Myocardial contractility dysfunction in patients with chronic lymphocytic leukemia receiving chemotherapy and their treatment with enalapril
IL Davydkin, TP Kuzmina… - Russian Journal of …, 2019 - russjcardiol.elpub.ru
Aim. To assess eft ventricular (LV) contractility dysfunction in patients with chronic
lymphocytic leukemia (CLL) receiving chemotherapy with fludarabine, cyclophosphamide …
lymphocytic leukemia (CLL) receiving chemotherapy with fludarabine, cyclophosphamide …
Evaluación de la cardiotoxicidad temprana asociada al tratamiento con antraciclinas en niños con Leucemia. Estudio prospectivo.
A Linares Ballesteros, R Sanguino Lobo… - Colombia …, 2021 - search.ebscohost.com
Antecedentes: Las leucemias son la principal causa de cáncer infantil. Los avances en el
tratamiento han llevado a los pacientes a una supervivencia global hasta del 80%. Cerca …
tratamiento han llevado a los pacientes a una supervivencia global hasta del 80%. Cerca …
[PDF][PDF] Research Article Sildenafil for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: A Phase I/II Randomized Clinical Trial, SILDAT-TAHA6 Trial
Background. Previous animal studies have shown a protective effect of 5-
phosphodiesterase inhibitors on cancer therapeuticsrelated cardiac dysfunction (CTRCD) of …
phosphodiesterase inhibitors on cancer therapeuticsrelated cardiac dysfunction (CTRCD) of …